Cancer, Ovarian Terminated Phase 1 Trials for Aldesleukin (DB00041)

Also known as: Cancer of the Ovary / Ovarian Cancer / Ovary Cancer / Cancer of Ovary / Ca ovary / Malignant tumor of ovary / Malignant neoplasm of ovary / Ovarian cancer NOS

IndicationStatusPhase
DBCOND0063542 (Cancer, Ovarian)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01212887Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With CancerTreatment